A pilot study of the efficacy of miglitol and sitagliptin for type 2diabetes with a continuous glucose monitoring system and incretin-related markers

BACKGROUND: Glucose fluctuations including robust postprandial hyperglycemia are a risk for promoting atherosclerosis and diabetic complications. The α-glucosidase inhibitors and the dipeptidyl peptidase-4 (DPP-4) inhibitors have been found to effectively decrease postprandial hyperglycemia independ...

Descripción completa

Detalles Bibliográficos
Autores principales: Kishimoto, Miyako, Noda, Mitsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307032/
https://www.ncbi.nlm.nih.gov/pubmed/22189184
http://dx.doi.org/10.1186/1475-2840-10-115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307032/
https://www.ncbi.nlm.nih.gov/pubmed/22189184
http://dx.doi.org/10.1186/1475-2840-10-115

Ejemplares similares